Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 8816059

Method for predicting and detecting tumor metastasis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8808684

Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8795680

Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8796302

Methods related to the treatment of neurodegenerative and inflammatory conditions

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8796291

A3 adenosine receptor antagonists and partial agonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8795964

GRM3 mutations and use thereof for the diagnosis and treatment of melanoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8795674

Methods and compositions for modulating immune tolerance

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8791074

Mutated anthrax toxin protective antigen proteins that specifically target cells containin

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8790869

Renal cell carcinoma biomarkers

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8790635

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8785601

T cell receptors and related materials and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8785414

Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögre

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8779095

LAT adapter molecule for enhanced T-cell signaling and method of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8778354

Compositions and methods for modulating RSV infection and immunity

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8772256

Codon modified immunogenic compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8759014

Methods of obtaining antigen-specific T cell populations

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8754046

MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8754081

Compositions and methods for inhibition of hepatocyte growth factor receptor c-Met signali

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8753649

Polysaccharide-protein conjugate vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8754030

Defensin-antigen fusion proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8748572

RNase a peptides, fragments and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8748390

Immunogenic epitopes of NGEP antigen

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8741649

Methods for enhancing genome stability and telomere elongation in embryonic stem cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8741313

Polypeptide vaccine and vaccination strategy against mycobacterium

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)